HHS Team Heads To England To Analyze Fluvirin Data

CBER Director Jesse Goodman will lead team in discussions with the U.K. regulatory agency. HHS Secretary Thompson hopes to secure a partial release of Fluvirin doses following suspension of Chiron’s license to manufacture influenza vaccine for three months.